Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CARCINOMA CELL-LINES' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 586 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rubinchik, S; Wang, D; Yu, H; Fan, F; Luo, M; Norris, JS; Dong, JY
      A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression

      MOLECULAR THERAPY
    2. Salahshor, S; Lei, HX; Huo, HG; Kristensen, VN; Loman, N; Sjoberg-Margolin, S; Borg, A; Borresen-Dale, AL; Vorechovsky, I; Lindblom, A
      Low frequency of E-cadherin alterations in familial breast cancer

      BREAST CANCER RESEARCH
    3. Perez, JM; Cerrillo, V; Matesanz, AI; Millan, JM; Navarro, P; Alonso, C; Souza, P
      DNA interstrand cross-linking efficiency and cytotoxic activity of novel cadmium(II) - Thiocarbodiazone complexes

      CHEMBIOCHEM
    4. Goluboff, ET
      Exisulind, a selective apoptotic antineoplastic drug

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    5. Salahshor, S; Hou, H; Diep, CB; Loukola, A; Zhang, H; Liu, T; Chen, J; Iselius, L; Rubio, C; Lothe, RA; Aaltonen, L; Sun, XF; Lindmark, G; Lindblom, A
      A germline E-cadherin mutation in a family with gastric and colon cancer

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    6. Harvey, S; Zhang, Y; Landry, F; Miller, C; Smith, JW
      Insights into a plasma membrane signature

      PHYSIOLOGICAL GENOMICS
    7. Gan, YB; Mo, YQ; Kalns, JE; Lu, J; Danenberg, K; Danenberg, P; Wientjes, MG; Au, JLS
      Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin c activity in human bladder tumors

      CLINICAL CANCER RESEARCH
    8. Qin, CH; Wilson, C; Blancher, C; Taylor, M; Safe, S; Harris, AL
      Association of ARNT splice variants with estrogen receptor-negative breastcancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis

      CLINICAL CANCER RESEARCH
    9. Nakopoulou, L; Gakiopoulou, H; Zervas, A; Giannopoulou, I; Constantinides, C; Lazaris, AC; Liapis, H; Kyriakou, G; Dimopoulos, C
      MMP-3 mRNA and MMP-3 and MMP-1 proteins in bladder cancer: A comparison with clinicopathologic features and survival

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    10. Tjiong, MY; Out, TA; Ter Schegget, J; Burger, MPM; Van der Vange, N
      Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: A review

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    11. Ohta, M; Isobe, K; Kuyama, J; Uchida, Y; Nakano, K; Goto, S; Uno, T; Yasuda, S; Shigematsu, N; Kawata, T; Kitahara, H; Ito, H
      Clinical role of Tc-99m-MIBI scintigraphy in non-Hodgkin's lymphoma

      ONCOLOGY REPORTS
    12. Waltmire, CN; Alberts, DS; Dorr, RT
      Sequence-dependent cytotoxicity of combination chemotherapy using paclitaxel, carboplatin and bleomycin in human lung and ovarian cancer

      ANTI-CANCER DRUGS
    13. Abe, A; Yamane, M; Tomoda, A
      Prevention of growth of human lung carcinoma cells and induction of apoptosis by a novel phenoxazinone, 2-amino-4,4 alpha-dihydro-4 alpha,7-dimethyl-3H-phenoxazine-3-one

      ANTI-CANCER DRUGS
    14. Tonin, PN; Hudson, TJ; Rodier, F; Bossolasco, M; Lee, PD; Novak, J; Manderson, EN; Provencher, D; Mes-Masson, AM
      Microarray analysis of gene expression mirrors the biology of an ovarian cancer model

      ONCOGENE
    15. Thomas, M; Glaunsinger, B; Pim, D; Javier, R; Banks, L
      HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation

      ONCOGENE
    16. Piccart, MJ; Lamb, H; Vermorken, JB
      Current and future potential roles of the platinum drugs in the treatment of ovarian cancer

      ANNALS OF ONCOLOGY
    17. Maehara, Y; Oda, S; Sugimachi, K
      The instability within: problems in current analyses of microsatellite instability

      MUTATION RESEARCH-DNA REPAIR
    18. Ascano, JJ; Frierson, H; Moskaluk, CA; Harper, JC; Roviello, F; Jackson, CE; El-Rifai, W; Vindigni, C; Tosi, P; Powell, SM
      Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer

      MODERN PATHOLOGY
    19. Karelina, Y; Baldwin, GS
      Binding sites for progastrin-derived peptides in colonic crypts

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    20. Savarese, DM; Halabi, S; Hars, V; Akerley, WL; Taplin, ME; Godley, PA; Hussain, A; Small, EJ; Vogelzang, NJ
      Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: A final report of CALGB 9780

      JOURNAL OF CLINICAL ONCOLOGY
    21. Kebebew, E; Treseler, PA; Ituarte, PHG; Clark, OH
      Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited

      WORLD JOURNAL OF SURGERY
    22. Wakasugi, S; Ohta, K; Hasegawa, Y; Tatumi, N; Nakamura, H
      Defection of minimal residual disease in acute leukemia by Tc-99m MIBI femoral marrow imaging

      CLINICAL NUCLEAR MEDICINE
    23. Didelot, C; Barberi-Heyob, M; Bianchi, A; Becuwe, P; Mirjolet, JF; Dauca, M; Merlin, JL
      Constitutive NF-kappa B activity influences basal apoptosis and radiosensitivity of head-and-neck carcinoma cell lines

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    24. Baker, AF; Dorr, RT
      Drug interactions with the taxanes: clinical implications

      CANCER TREATMENT REVIEWS
    25. Bollag, WB; Bollag, RJ
      1,25-Dihydroxyvitamin D-3,D- phospholipase D and protein kinase C in keratinocyte differentiation

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    26. Hayashi, K; Yokozaki, H; Goodison, S; Oue, N; Suzuki, T; Lotan, R; Yasui, N; Tahara, E
      Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer

      DIFFERENTIATION
    27. Massimi, P; Pim, D; Kuhne, C; Banks, L
      Regulation of the human papillomavirus oncoproteins by differential phosphorylation

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    28. Rorison, KA; Lee, DJ; Baldwin, GS
      Mutation of lysine residues of the 78-kDa gastrin-binding protein reduces gastrin binding

      JOURNAL OF PROTEIN CHEMISTRY
    29. Johanning, GL; Cope, MB; Wilborn, T; Grubbs, CJ; Lubet, RA
      Effect of high retinoid doses on RAR-beta mRNA expression in female B6D2F1mice

      ANTICANCER RESEARCH
    30. Hildebrandt, T; Van Dijk, MCRF; Van Muijen, GNP; Weidle, UH
      Loss of heterozygosity of gene THW is frequently found in melanoma metastases

      ANTICANCER RESEARCH
    31. Saegusa, Y; Eriguchi, M; Kidani, Y; Matsuzawa, A; Takeda, Y
      Antitumor effects of a new lipophilic platinum compound, trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), in mice

      ANTICANCER RESEARCH
    32. Devilee, P; Cleton-Jansen, AM; Cornelisse, CJ
      Ever since Knudson

      TRENDS IN GENETICS
    33. Vigano, L; Locatelli, A; Grasselli, G; Gianni, L
      Drug interactions of paclitaxel and docetaxel and their relevance for the design of combination therapy

      INVESTIGATIONAL NEW DRUGS
    34. Grivicich, I; Mans, DRA; Peters, GJ; Schwartsmann, G
      Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    35. Prinsloo, SE; Van Aswegen, CH
      The role of receptors in prostate cancer

      ADVANCES IN CLINICAL CHEMISTRY, VOL 35
    36. Harrington, KJ; Spitzweg, C; Bateman, AR; Morris, JC; Vile, RG
      Gene therapy for prostate cancer: Current status and future prospects

      JOURNAL OF UROLOGY
    37. Vakili, J; Standker, L; Detheux, M; Vassart, G; Forssmann, WG; Parmentier, M
      Urokinase plasminogen activator and plasmin efficiently convert hemofiltrate CC chemokine 1 into its active [9-74] processed variant

      JOURNAL OF IMMUNOLOGY
    38. Player, AN; Shen, LP; Kenny, D; Antao, VP; Kolberg, JA
      Single-copy gene detection using branched DNA (bDNA) in situ hybridization

      JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
    39. Aquilina, G; Bignami, M
      Mismatch repair in correction of replication errors and processing of DNA damage

      JOURNAL OF CELLULAR PHYSIOLOGY
    40. Tikhomirov, O; Carpenter, G
      Caspase-dependent cleavage of ErbB-2 by geldanamycin and staurosporin

      JOURNAL OF BIOLOGICAL CHEMISTRY
    41. Kawakami, K; Takeshita, F; Puri, RK
      Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain

      JOURNAL OF BIOLOGICAL CHEMISTRY
    42. Abdel-Ghany, M; Cheng, HC; Elble, RC; Pauli, BU
      The breast cancer beta(4) integrin and endothelial human CLCA2 mediate lung metastasis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    43. Grigorian, M; Andresen, S; Tulchinsky, E; Kriajevska, M; Carlberg, C; Kruse, C; Cohn, M; Ambartsumian, N; Christensen, A; Selivanova, G; Lukanidin, E
      Tumor suppressor p53 protein is a new target for the metastasis-associatedMts1/S100A4 protein - Functional consequences of their interaction

      JOURNAL OF BIOLOGICAL CHEMISTRY
    44. Evans, CP; Stapp, EC; Dall'Era, MA; Juarez, J; Yang, JC
      Regulation of u-PA gene expression in human prostate cancer

      INTERNATIONAL JOURNAL OF CANCER
    45. Cho, YS; Kang, JW; Cho, M; Cho, CW; Lee, S; Choe, YK; Kim, Y; Choi, I; Park, SN; Kim, S; Dinarello, CA; Yoon, DY
      Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18

      FEBS LETTERS
    46. Yu, DC; Chen, Y; Dilley, J; Li, YH; Embry, M; Zhang, H; Nguyen, N; Amin, P; Oh, J; Henderson, DR
      Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel

      CANCER RESEARCH
    47. Chen, R; Eshleman, JR; Brodsky, RA; Medof, ME
      Glycophosphatidylinositol-anchored protein deficiency as a marker of Mutator phenotypes in cancer

      CANCER RESEARCH
    48. Joshi, BH; Plautz, GE; Puri, RK
      Correspondence re: B. H. Joshi et al., interleukin-13 receptor alpha chain: A novel tumor-associated transmembrane protein in primary explants of human malignant gliomas. Cancer Res., 60 : 1168-1172, 2000. Reply

      CANCER RESEARCH
    49. Dumon, KR; Ishii, H; Vecchione, A; Trapasso, F; Baldassarre, G; Chakrani, F; Druck, T; Rosato, EF; Williams, NN; Baffa, R; During, MJ; Huebner, K; Croce, CM
      Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer

      CANCER RESEARCH
    50. Kawakami, K; Taguchi, J; Murata, T; Puri, RK
      The interleukin-13 receptor alpha 2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway

      BLOOD
    51. Baldwin, GS
      Inhibition of the preferential binding of actin to the N-terminal hydratase domain of the 78-kDa gastrin-binding protein by nonsteroidal anti-inflammatory drugs and gastrin receptor antagonists

      BIOCHEMICAL PHARMACOLOGY
    52. Eandi, JA; Yang, JC; Evans, CP
      Signal transduction-mediated regulation of urokinase gene expression in human prostate cancer

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    53. Nagata, J; Kijima, H; Hatanaka, H; Asai, S; Miyachi, H; Takagi, A; Miwa, T; Mine, T; Yamazaki, H; Nakamura, M; Kondo, T; Scanlon, KJ; Ueyama, Y
      Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    54. Lee, SH; Kim, WH; Kim, HK; Woo, KM; Nam, HS; Kim, HS; Kim, JG; Cho, MH
      Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    55. Eriksson, A; Yachnin, J; Lewensohn, R; Nilsso, A
      DNA-dependent protein kinase is inhibited by trifluoperazine

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    56. Howe, JA; Demers, GW; Johnson, DE; Neugebauer, SEA; Perry, ST; Vaillancourt, MT; Faha, B
      Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapy

      MOLECULAR THERAPY
    57. Moretti, F; Nanni, S; Pontecorvi, A
      Molecular pathogenesis of thyroid nodules and cancer

      BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    58. Ain, KB
      Management of undifferentiated thyroid cancer

      BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    59. Korte, W
      Changes of the coagulation and fibrinolysis system in malignancy: Their possible impact on future diagnostic and therapeutic procedures

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    60. Cassidy, J
      Review of oxaliplatin: An active platinum agent in colorectal cancer

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    61. Greenberg, NM
      Androgens and growth factors in prostate cancer: a transgenic perspective

      PROSTATE CANCER AND PROSTATIC DISEASES
    62. Aust, G; Simchen, C; Heider, U; Hmeidan, FA; Blumenauer, V; Spanel-Borowski, K
      Eosinophils in the human corpus luteum: the role of RANTES and eotaxin in eosinophil attraction into periovulatory structures

      MOLECULAR HUMAN REPRODUCTION
    63. Kelland, LR
      An update on satraplatin: the first orally available platinum anticancer drug

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    64. Makar, AP
      Hormone therapy in epithelial ovarian cancer

      ENDOCRINE-RELATED CANCER
    65. Graham, MA; Lockwood, GF; Greenslade, D; Brienza, S; Bayssas, M; Gamelin, E
      Clinical pharmacokinetics of oxaliplatin: A critical review

      CLINICAL CANCER RESEARCH
    66. Sauter, ER; Herlyn, M; Liu, SC; Litwin, S; Ridge, JA
      Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model

      CLINICAL CANCER RESEARCH
    67. Chiappetta, G; Tallini, G; De Biasio, MC; Pentimalli, F; de Nigris, F; Losito, S; Fedele, M; Battista, S; Verde, P; Santoro, M; Fusco, A
      FRA-1 expression in hyperplastic and neoplastic thyroid diseases

      CLINICAL CANCER RESEARCH
    68. Su, TL; Lin, CT; Chen, CH; Lin, MT
      Synthesis and antitumor evaluation of water-soluble derivatives of glyfoline

      MEDICINAL CHEMISTRY RESEARCH
    69. Schmutzler, C; Kohrle, J
      Retinoic acid redifferentiation therapy for thyroid cancer

      THYROID
    70. Kraiem, Z; Korem, S
      Matrix metalloproteinases and the thyroid

      THYROID
    71. Hilgers, W; Koerkamp, BG; Geradts, J; Tang, DJ; Yeo, CJ; Hruban, RH; Kern, SE
      Genomic FHIT analysis in RER+ and RER- adenocarcinomas of the pancreas

      GENES CHROMOSOMES & CANCER
    72. Perez, JM; Fuertes, MA; Alonso, C; Navarro-Ranninger, C
      Current status of the development of trans-platinum antitumor drugs

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    73. Putzer, BM; Stiewe, T; Crespo, F; Esche, H
      Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy

      GENE THERAPY
    74. Shin, KH; Park, JG
      Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair proteins hMSH2 and hMLH1

      EUROPEAN JOURNAL OF CANCER
    75. Huiping, C; Jonasson, JG; Agnarsson, BA; Sigbjornsdottir, BI; Huebner, K; Ingvarsson, S
      Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer

      EUROPEAN JOURNAL OF CANCER
    76. Kuraguchi, M; Edelmann, W; Yang, K; Lipkin, M; Kucherlapati, R; Brown, AMC
      Tumor-associated Apc mutations in Mlh1(-/-) Apc(1638N) mice reveal a mutational signature of Mlh1 deficiency

      ONCOGENE
    77. Lin, WC; Kao, HW; Robinson, D; Kung, HJ; Wu, CW; Chen, HC
      Tyrosine kinases and gastric cancer

      ONCOGENE
    78. Krieg, M; Haas, R; Brauch, H; Acker, T; Flamme, I; Plate, KH
      Up-regulation of hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function

      ONCOGENE
    79. Modi, S; Kubo, A; Oie, H; Coxon, AB; Rehmatulla, A; Kaye, FJ
      Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer

      ONCOGENE
    80. Jackson, S; Storey, A
      E6 proteins from diverse cutaneous HPV types inhibit apoptosis in responseto UV damage

      ONCOGENE
    81. Cormier, RT; Bilger, A; Lillich, AJ; Halberg, RB; Hong, KH; Gould, KA; Borenstein, N; Lander, ES; Dove, WF
      The Mom1(AKR) intestinal tumor resistance region consists of Pla2g2a and alocus distal to D4Mit64

      ONCOGENE
    82. Ma, AH; Xia, L; Littman, SJ; Swinler, S; Lader, G; Polinkovsky, A; Olechnowicz, J; Kasturi, L; Lutterbaugh, J; Modrich, P; Veigl, ML; Markowitz, SD; Sedwick, WD
      Somatic mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability

      ONCOGENE
    83. Chuang, LY; You, HL; Tsai, JF
      Epidermal growth factor receptor-binding growth factors in the urine of patients with cancers of the digestive tract

      JOURNAL OF GASTROENTEROLOGY
    84. Wen, SF; Xie, L; McDonald, M; DiGiacomo, R; Chang, A; Gurnani, M; Shi, B; Liu, SX; Indelicato, SR; Hutchins, B; Nielsen, LL
      Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models

      CANCER GENE THERAPY
    85. Komori, T; Narabayashi, I; Matsui, R; Sueyoshi, K; Aratani, T; Utsunomiya, K
      Technetium-99m MIBI single photon emission computed tomography as an indicator of prognosis for patients with lung cancer - Preliminaly report

      ANNALS OF NUCLEAR MEDICINE
    86. Lau, YFC; Zhang, JQ
      Expression analysis of thirty one Y chromosome genes in human prostate cancer

      MOLECULAR CARCINOGENESIS
    87. Yaginuma, Y; Yamashita, T; Ishiya, T; Morizaki, A; Katoh, Y; Takahashi, T; Hayashi, H; Ishikawa, M
      Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers

      MOLECULAR CARCINOGENESIS
    88. Rothenberg, ML
      Efficacy of oxaliplatin in the treatment sf colorectal cancer

      ONCOLOGY-NEW YORK
    89. Schmutzler, C; Koehrle, J
      Innovative strategies for the treatment of thyroid cancer

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    90. Markowitz, S
      DNA repair defects inactivate tumor suppressor genes and induce hereditaryand sporadic colon cancers

      JOURNAL OF CLINICAL ONCOLOGY
    91. Liu, YM; McKalip, A; Herman, B
      Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: Roles of p53 and caspase activation

      JOURNAL OF CELLULAR BIOCHEMISTRY
    92. Vanhoefer, U; Achterrath, W; Wilke, H; Seeber, S
      Preclinical evaluation of irinotecan

      ONKOLOGIE
    93. Goretzki, PE; Simon, D; Dotzenrath, C; Schulte, KM; Roher, HD
      Growth regulation of thyroid and thyroid tumors in humans

      WORLD JOURNAL OF SURGERY
    94. Caffrey, PB; Frenkel, GD
      Selenium compounds prevent the induction of drug resistance by cisplatin in human ovarian tumor xenografts in vivo

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    95. Lewis, JS; Dearling, JLJ; Sosabowski, JK; Zweit, J; Carnochan, P; Kelland, LR; Coley, HM; Blower, PJ
      Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    96. Rigas, B; Shiff, SJ
      Is inhibition of cyclooxygenase required for the chemopreventive effect ofNSAIDs in colon cancer? A model reconciling the current contradiction

      MEDICAL HYPOTHESES
    97. Ara, T; Deyama, Y; Yoshimura, Y; Higashino, F; Shindoh, M; Matsumoto, A; Fukuda, H
      Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade

      CANCER LETTERS
    98. Lemma, K; Sargeson, AM; Elding, LI
      Kinetics and mechanism for reduction of oral anticancer platinum(IV) dicarboxylate compounds by L-ascorbate ions

      JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS
    99. Jones, MW; Kounelis, S; Papadaki, H; Bakker, A; Swalsky, PA; Woods, J; Finkelstein, SD
      Well-differentiated villoglandular adenocarcinoma of the uterine cervix: Oncogene/tumor suppressor gene alterations and human papillomavirus genotyping

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    100. Stoler, MH
      Human papillomaviruses and cervical neoplasia: A model for carcinogenesis

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 13:36:56